» Articles » PMID: 27159591

An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein

Overview
Journal PLoS One
Date 2016 May 10
PMID 27159591
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian S100B protein plays multiple important roles in cellular brain processes. The protein is a clinically used marker for several pathologies including brain injury, neurodegeneration and cancer. High levels of S100B released by astrocytes in Down syndrome patients are responsible for reduced neurogenesis of neural progenitor cells and induction of cell death in neurons. Despite increasing understanding of S100B biology, there are still many questions concerning the detailed molecular mechanisms that determine specific activities of S100B. Elevated overexpression of S100B protein is often synchronized with increased nitric oxide-related activity. In this work we show S100B is a target of exogenous S-nitrosylation in rat brain protein lysate and identify endogenous S-nitrosylation of S100B in a cellular model of astrocytes. Biochemical studies are presented indicating S-nitrosylation tunes the conformation of S100B and modulates its Ca2+ and Zn2+ binding properties. Our in vitro results suggest that the possibility of endogenous S-nitrosylation should be taken into account in the further studies of in vivo S100B protein activity, especially under conditions of increased NO-related activity.

Citing Articles

Differential scanning fluorimetry followed by microscale thermophoresis and/or isothermal titration calorimetry as an efficient tool for ligand screening.

Winiewska-Szajewska M, Poznanski J Biophys Rev. 2025; 17(1):199-223.

PMID: 40060009 PMC: 11885780. DOI: 10.1007/s12551-025-01280-3.


The Angiotensin Metabolite His-Leu Is a Strong Copper Chelator Forming Highly Redox Active Species.

Wezynfeld N, Sudzik D, Tobolska A, Makarova K, Stefaniak E, Fraczyk T Inorg Chem. 2024; 63(26):12268-12280.

PMID: 38877980 PMC: 11220758. DOI: 10.1021/acs.inorgchem.4c01640.


Secondary Modification of S100B Influences Anti Amyloid-β Aggregation Activity and Alzheimer's Disease Pathology.

Coelho R, De Benedictis C, Sauer A, Figueira A, Faustino H, Grabrucker A Int J Mol Sci. 2024; 25(3).

PMID: 38339064 PMC: 10855146. DOI: 10.3390/ijms25031787.


From methodological limitations to the function of metallothioneins - a guide to approaches for determining weak, moderate, and tight affinity zinc sites.

Pomorski A, Drozd A, Kocyla A, Krezel A Metallomics. 2023; 15(5).

PMID: 37113075 PMC: 10210066. DOI: 10.1093/mtomcs/mfad027.


Intracellular Protein S-Nitrosylation-A Cells Response to Extracellular S100B and RAGE Receptor.

Zareba-Koziol M, Burdukiewicz M, Wyslouch-Cieszynska A Biomolecules. 2022; 12(5).

PMID: 35625541 PMC: 9138530. DOI: 10.3390/biom12050613.


References
1.
Hashemy S, Holmgren A . Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J Biol Chem. 2008; 283(32):21890-8. DOI: 10.1074/jbc.M801047200. View

2.
Kohr M, Aponte A, Sun J, Wang G, Murphy E, Gucek M . Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol. 2011; 300(4):H1327-35. PMC: 3075037. DOI: 10.1152/ajpheart.00997.2010. View

3.
Forrester M, Foster M, Stamler J . Assessment and application of the biotin switch technique for examining protein S-nitrosylation under conditions of pharmacologically induced oxidative stress. J Biol Chem. 2007; 282(19):13977-83. DOI: 10.1074/jbc.M609684200. View

4.
Wilder P, Baldisseri D, Udan R, Vallely K, Weber D . Location of the Zn(2+)-binding site on S100B as determined by NMR spectroscopy and site-directed mutagenesis. Biochemistry. 2003; 42(46):13410-21. DOI: 10.1021/bi035334q. View

5.
Jaffrey S, Erdjument-Bromage H, Ferris C, Tempst P, Snyder S . Protein S-nitrosylation: a physiological signal for neuronal nitric oxide. Nat Cell Biol. 2001; 3(2):193-7. DOI: 10.1038/35055104. View